Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Low-Voltage Area-Guided Ablation for Persistent Atrial Fibrillation: A Meta-Analysis of Randomized Trials.

Created on 18 Nov 2026

Authors

Husam Kivan, Hamza Sondoqah, Abdulah Mohammad Abd Alhamed Abou Kaff, Mohamed Eldahrawy, Areej Makeineldein Mustafa, April Htoon, Farah Qandeel, Ahmad Alababneh, Ammar Khalid, Ahmed L Youseif, Hamzah M Alghzawi, Mohamed Ibraheem

Published in

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. Volume 31. Issue 6.

Abstract

Low-voltage areas (LVAs) may represent arrhythmogenic substrate in persistent atrial fibrillation (AF), but the benefit of adjunctive LVA-guided ablation remains uncertain.
We performed a PRISMA-compliant systematic review and random-effects meta-analysis of randomized controlled trials comparing LVA-guided ablation with non-LVA-guided strategies in persistent or non-paroxysmal AF. Searches were updated through September 2, 2026. The primary outcome was atrial arrhythmia recurrence; time-to-event hazard ratios (HRs), repeat ablation, procedural outcomes, and safety were secondary outcomes.
Eight randomized trials involving 1656 patients contributed to the primary analysis. LVA-guided ablation reduced atrial arrhythmia recurrence (RR 0.77, 95% CI 0.65-0.91; p = 0.003; I2 = 36.6%), although the 95% prediction interval included no benefit (0.51-1.17). The pooled HR was also favorable (HR 0.71, 95% CI 0.53-0.96; p = 0.026; I2 = 67.2%). Omitting IDEAL-AF attenuated both estimates and eliminated most heterogeneity. Mapping-before-randomization trials with documented LVAs did not differ from randomization-before-mapping trials (interaction p = 0.76). Repeat ablation was reduced (RR 0.69, 95% CI 0.49-0.97), while procedure time, fluoroscopy time, and major safety outcomes were not significantly different.
LVA-guided ablation was associated with fewer atrial arrhythmia recurrences and repeat procedures, but the pooled effect was strongly influenced by IDEAL-AF and remained heterogeneous across documented-LVA trials. Standardized mapping and ablation protocols are needed before the magnitude of benefit can be considered established.

PMID:
43046627
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement